• HOME
  • Publication
  • 「Does a third party infringe a patent right by conducting clinical trials on an original drug?」

Publications

Our professionals’ books, and articles on external publications.
For Publications relating to IP in General, Copyright, Unfair Competition, Plant Variety Protection, etc.,
please select “Intellectual Property.”

「Does a third party infringe a patent right by conducting clinical trials on an original drug?」

Practices:Intellectual Property、Patents

Category:Others

Authors YAMAMOTO, Osamu    
Practice Areas Intellectual Property Patents
Date of publication Issue May / June 2021
Publication carrying this article The Patent Lawyer
Publisher CTC Legal Media

PDF Download

Summary

Osamu Yamamoto explains the impact of the recent Intellectual Property High Court decision Reiwa 2 (Ne) 10051, as well as the necessity for reforming the patent system relating to drug marketing approval in Japan.

Other works by YAMAMOTO, Osamu

Other works on Intellectual Property、Patents

Telephone

+81(3)3270-6641

E-mail for Enquiries

Click Here

HOME

Back to Top

Section 206, Shin-Otemachi Bldg.
2-1, Otemachi 2-Chome
Chiyoda-Ku, Tokyo 100-0004, Japan
Tel.81-3-3270-6641
Fax.81-3-3246-0233

DISCLAIMER:

  • The contents of this site provide readers with general information and are not legal advice.
  • YUASA AND HARA is not responsible to readers who act upon the information　contained in this site.
  • Feel free to link to our website. You do not need to contact us to confirm our permission. We would like to ask that you exercise common sense when linking to our website in order to avoid violating laws, public order or morals.
  • In the case of inappropriate links, such as those that harm the trust or reputation of our firm, we will request you to delete such links. Thank you for your understanding in advance.

Our privacy policy applies to our online/offline handling of your personal information.